000168312 001__ 168312
000168312 005__ 20260204153542.0
000168312 0247_ $$2doi$$a10.1152/ajpheart.00914.2014
000168312 0248_ $$2sideral$$a90413
000168312 037__ $$aART-2015-90413
000168312 041__ $$aeng
000168312 100__ $$0(orcid)0000-0003-2644-9386$$aLegaz-Arrese, A.$$uUniversidad de Zaragoza
000168312 245__ $$aImpact of an endurance training program on exercise-induced cardiac biomarker release
000168312 260__ $$c2015
000168312 5060_ $$aAccess copy available to the general public$$fUnrestricted
000168312 5203_ $$aWe evaluated the influence of a 14-wk endurance running program on the exercise-induced release of high-sensitivity cardiac troponin T (hs-cTnT) and NH2-terminal pro-brain natriuretic peptide (NT-proBNP). Fifty-eight untrained participants were randomized to supervised endurance exercise (14 wk, 3–4 days/wk, 120–240 min/wk, 65–85% of maximum heart rate) or a control group. At baseline and after the training program, hs-cTnT and NT-proBNP were assessed before and 5 min, 1 h, 3 h, 6 h, 12 h, and 24 h after a 60-min maximal running test. Before training, hs-cTnT was significantly elevated in both groups with acute exercise (P < 0.0001) with no between-group differences. There was considerable heterogeneity in peak hs-cTnT concentration with the upper reference limit exceeded in 71% of the exercise tests. After training, both baseline and postexercise hs-cTnT were significantly higher compared with pretraining and the response of the control group (P = 0.008). Acute exercise led to a small but significant increase in NT-proBNP, but this was not mediated by training (P = 0.121). In summary, a controlled endurance training intervention resulted in higher pre- and postexercise values of hs-cTnT with no changes in NT-proBNP.
000168312 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000168312 590__ $$a3.324$$b2015
000168312 591__ $$aCARDIAC & CARDIOVASCULAR SYSTEMS$$b39 / 124 = 0.315$$c2015$$dQ2$$eT1
000168312 591__ $$aPHYSIOLOGY$$b21 / 83 = 0.253$$c2015$$dQ2$$eT1
000168312 591__ $$aPERIPHERAL VASCULAR DISEASE$$b17 / 63 = 0.27$$c2015$$dQ2$$eT1
000168312 592__ $$a1.883$$b2015
000168312 593__ $$aCardiology and Cardiovascular Medicine$$c2015$$dQ1
000168312 593__ $$aPhysiology (medical)$$c2015$$dQ1
000168312 593__ $$aPhysiology$$c2015$$dQ1
000168312 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000168312 700__ $$0(orcid)0000-0002-9304-3709$$aLópez-Laval, I.
000168312 700__ $$aGeorge, K.
000168312 700__ $$0(orcid)0000-0002-7213-7095$$aPuente-Lanzarote, J.
000168312 700__ $$0(orcid)0000-0003-0721-2447$$aMayolas-Pi, C.$$uUniversidad de Zaragoza
000168312 700__ $$0(orcid)0000-0002-8170-9403$$aSerrano-Ostáriz, E.$$uUniversidad de Zaragoza
000168312 700__ $$aRevilla-Martí, P.
000168312 700__ $$aMoliner-Urdiales, D.
000168312 700__ $$aReverter-Masià, J.
000168312 7102_ $$11006$$2245$$aUniversidad de Zaragoza$$bDpto. Fisiatría y Enfermería$$cÁrea Educación Física y Depor.
000168312 773__ $$g308, 8 (2015), H913-H920$$pAm. j. physiol, Heart circ. physiol.$$tAMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY$$x0363-6135
000168312 8564_ $$s805103$$uhttps://zaguan.unizar.es/record/168312/files/texto_completo.pdf$$yVersión publicada
000168312 8564_ $$s3953310$$uhttps://zaguan.unizar.es/record/168312/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000168312 909CO $$ooai:zaguan.unizar.es:168312$$particulos$$pdriver
000168312 951__ $$a2026-02-04-13:13:31
000168312 980__ $$aARTICLE